Experienced in Bullae

Dr. Jeffrey Travers

Dermatology
Wright State Physicians Inc.
725 Colonel Glenn Hwy, 
Dayton, OH 
Experienced in Bullae
Wright State Physicians Inc.
725 Colonel Glenn Hwy, 
Dayton, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Travers is a Dermatologist in Dayton, Ohio. Dr. Travers is rated as an Experienced provider by MediFind in the treatment of Bullae. His top areas of expertise are Actinic Keratosis, Atopic Dermatitis, Melanoma, Psoriasis, and Vertebroplasty.

His clinical research consists of co-authoring 141 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Bullae.

Specialties
Dermatology
Licenses
Dermatology in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Wright State Physicians Inc.
725 Colonel Glenn Hwy, Dayton, OH 45435
Call: 937-245-7200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
Enrollment Status: Withdrawn
Publish Date: April 09, 2025
Intervention Type: Other, Drug
Study Drug: Nomacopan
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 1
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

141 Total Publications

Possible involvement of keratinocyte-derived microvesicle particles in human photosensitivity disorders.
Possible involvement of keratinocyte-derived microvesicle particles in human photosensitivity disorders.
Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025
View All 141 Publications
Similar Doctors
Distinguished in Bullae
Dr. Diya Mutasim
Dermatology
Distinguished in Bullae
Dr. Diya Mutasim
Dermatology

University Dermatology Consultants Inc

222 Piedmont Ave Ste 5300, 
Cincinnati, OH 
 (52.0 miles away)
513-475-7630
Languages Spoken:
English
See accepted insurances

Diya Mutasim is a Dermatologist in Cincinnati, Ohio. Dr. Mutasim is rated as a Distinguished provider by MediFind in the treatment of Bullae. His top areas of expertise are Basal Cell Skin Cancer, Bowen's Disease, Pustules, and Actinic Keratosis.

Advanced in Bullae
Dr. Kerith Spicknall
Dermatology
Advanced in Bullae
Dr. Kerith Spicknall
Dermatology

University Dermatology Consultants Inc

222 Piedmont Ave Ste 5300, 
Cincinnati, OH 
 (52.0 miles away)
513-475-7630
Languages Spoken:
English
See accepted insurances

Kerith Spicknall is a Dermatologist in Cincinnati, Ohio. Dr. Spicknall is rated as a Distinguished provider by MediFind in the treatment of Bullae. Her top areas of expertise are Pustules, Bowen's Disease, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.

Advanced in Bullae
Dr. Benjamin Kaffenberger
Dermatology
Advanced in Bullae
Dr. Benjamin Kaffenberger
Dermatology

Ohio State Dermatology West

1328 Dublin Rd Ste 100, 
Columbus, OH 
 (54.0 miles away)
614-293-1707
Languages Spoken:
English
See accepted insurances

Benjamin Kaffenberger is a Dermatologist in Columbus, Ohio. Dr. Kaffenberger is rated as an Elite provider by MediFind in the treatment of Bullae. His top areas of expertise are Pyoderma Gangrenosum, Cellulitis, DRESS Syndrome, Erythema Multiforme, and Tissue Biopsy.

VIEW MORE BULLAE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Travers's expertise for a condition
ConditionClose
    • Distinguished
    • Actinic Keratosis
      Dr. Travers is
      Distinguished
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Advanced
    • Atopic Dermatitis
      Dr. Travers is
      Advanced
      . Learn about Atopic Dermatitis.
      See more Atopic Dermatitis experts
    • Melanoma
      Dr. Travers is
      Advanced
      . Learn about Melanoma.
      See more Melanoma experts
    • Plaque Psoriasis
      Dr. Travers is
      Advanced
      . Learn about Plaque Psoriasis.
      See more Plaque Psoriasis experts
    • Psoriasis
      Dr. Travers is
      Advanced
      . Learn about Psoriasis.
      See more Psoriasis experts
    • Experienced
    • Alopecia Areata
      Dr. Travers is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Athlete's Foot
      Dr. Travers is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Autosomal Recessive Hypotrichosis
      Dr. Travers is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Basal Cell Skin Cancer
      Dr. Travers is
      Experienced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Bullae
      Dr. Travers is
      Experienced
      . Learn about Bullae.
      See more Bullae experts
    • Contact Dermatitis
      Dr. Travers is
      Experienced
      . Learn about Contact Dermatitis.
      See more Contact Dermatitis experts
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.